Satnam Surae, chief product officer, Aigenpulse examines how automation can benefit the pharma industry when it comes to data processing and analytics.
Isabel Losantos, senior consultant - Design Assurance, at Cambridge Consultants and Joe Corrigan, head of Medical Technology examine the potential AI represents in life sciences and the regulatory changes it brings.
European Pharmaceutical Manufacturer sits down with Derek Wang, CEO of data analytics company Stratifyd, to discuss the Covid-19 pandemic and how technology can be better used to predict and potentially curtail disease outbreaks.
Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus.
Neal Singh, COO, Icertis, discusses how advancements in artificial intelligence (AI) are helping pharmaceutical manufacturers better manage their supply chains.
Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.
The role AI can play in drug discovery and development is well documented, but the recent global pandemic has highlighted the growing importance this technology has in the fight against disease, writes Lu Rahman.
Andreas Gross - global product manager of Inspection Technology at Syntegon Technology, explains how artificial intelligence (AI) is being used to ensure pharmaceutical products are safe.
Ian Bolland speaks to Dr Chee Yang Chen, CEO of biotech Carta Biosciences, to discuss how artificial intelligence (AI) can reverse ageing, issues surrounding drug discovery, and the pressure put on healthcare systems because of care for the elderly.
Bruce Palsulich, vice president of Product Strategy, Oracle Health Sciences, explains how AI can help pharmaceutical companies gather more important data and boost pharmacovigilance.
Panna Sharma, CEO of clinical stage oncology biotech Lantern Pharma, speaks to EPM about how his company’s artificial intelligence platform could help revolutionise drug development and ultimately change the way we treat cancer.
